The aim of the studies was to define HLA genetics among MS patients not associated with HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.